QT Interval Prolongation Under Hydroxychloroquine/Azithromycin Association for Inpatients With SARS‐CoV‐2 Lower Respiratory Tract Infection

Use of drugs with potential cardiac effect in the setting of SARS-CoV-2 infection

(2020) Frederic Sacher et al.   Archives of Cardiovascular Diseases

Guidance on Minimizing Risk of Drug-Induced Ventricular Arrhythmia During Treatment of COVID-19: A Statement from the Canadian Heart Rhythm Society

(2020) John L. Sapp et al.   CANADIAN JOURNAL OF CARDIOLOGY

Optimizing Hydroxychloroquine Dosing for Patients With COVID‐19: An Integrative Modeling Approach for Effective Drug Repurposing

(2020) Maria Garcia‐Cremades et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

QT prolongation, torsades de pointes, and sudden death with short courses of chloroquine or hydroxychloroquine as used in COVID-19: A systematic review

(2020) Lior Jankelson et al.   HEART RHYTHM

The QT interval in patients with COVID-19 treated with hydroxychloroquine and azithromycin

(2020) Ehud Chorin et al.   NATURE MEDICINE

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)

(2020) Nicholas J. Mercuro et al.   JAMA Cardiology

Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit

(2020) Francis Bessière et al.   JAMA Cardiology

Urgent Guidance for Navigating and Circumventing the QTc-Prolonging and Torsadogenic Potential of Possible Pharmacotherapies for Coronavirus Disease 19 (COVID-19)

(2020) John R. Giudicessi et al.   MAYO CLINIC PROCEEDINGS

Sources of QTc variability: Implications for effective ECG monitoring in clinical practice

(2019) Katerina Hnatkova et al.   ANNALS OF NONINVASIVE ELECTROCARDIOLOGY

The arrhythmogenic cardiotoxicity of the quinoline and structurally related antimalarial drugs: a systematic review

(2018) Ilsa L. Haeusler et al.   BMC Medicine

Assessment of Multi-Ion Channel Block in a Phase I Randomized Study Design: Results of the CiPA Phase I ECG Biomarker Validation Study

(2018) Jose Vicente et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice

(2018) Young Choi et al.   Biomed Research International

Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide

(2016) PAUL GARABELLI et al.   JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY

Comprehensive Translational Assessment of Human-Induced Pluripotent Stem Cell Derived Cardiomyocytes for Evaluating Drug-Induced Arrhythmias

(2016) Ksenia Blinova et al.   TOXICOLOGICAL SCIENCES

Azithromycin is not associated with QT prolongation in hospitalized patients with community-acquired pneumonia

(2015) Lee Hilary Goldstein et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Azithromycin-Induced Proarrhythmia and Cardiovascular Death

(2014) Patricia A. Howard   ANNALS OF PHARMACOTHERAPY

Comparison of Manual and Automated Measurements of the QT Interval in Healthy Volunteers: An Analysis of Five Thorough QT Studies

(2009) C Fosser et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

AHA/ACCF/HRS Recommendations for the Standardization and Interpretation of the Electrocardiogram

(2009) Pentti M. Rautaharju et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY